1. Home
  2. ACNT vs ZNTL Comparison

ACNT vs ZNTL Comparison

Compare ACNT & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACNT
  • ZNTL
  • Stock Information
  • Founded
  • ACNT 1945
  • ZNTL 2014
  • Country
  • ACNT United States
  • ZNTL United States
  • Employees
  • ACNT N/A
  • ZNTL N/A
  • Industry
  • ACNT Steel/Iron Ore
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACNT Industrials
  • ZNTL Health Care
  • Exchange
  • ACNT Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • ACNT 123.7M
  • ZNTL 105.8M
  • IPO Year
  • ACNT N/A
  • ZNTL 2020
  • Fundamental
  • Price
  • ACNT $12.60
  • ZNTL $1.24
  • Analyst Decision
  • ACNT
  • ZNTL Buy
  • Analyst Count
  • ACNT 0
  • ZNTL 7
  • Target Price
  • ACNT N/A
  • ZNTL $8.60
  • AVG Volume (30 Days)
  • ACNT 136.2K
  • ZNTL 1.4M
  • Earning Date
  • ACNT 08-05-2025
  • ZNTL 08-08-2025
  • Dividend Yield
  • ACNT N/A
  • ZNTL N/A
  • EPS Growth
  • ACNT N/A
  • ZNTL N/A
  • EPS
  • ACNT N/A
  • ZNTL N/A
  • Revenue
  • ACNT $174,652,000.00
  • ZNTL $26,865,000.00
  • Revenue This Year
  • ACNT $22.72
  • ZNTL N/A
  • Revenue Next Year
  • ACNT N/A
  • ZNTL N/A
  • P/E Ratio
  • ACNT N/A
  • ZNTL N/A
  • Revenue Growth
  • ACNT 5.04
  • ZNTL N/A
  • 52 Week Low
  • ACNT $8.16
  • ZNTL $1.01
  • 52 Week High
  • ACNT $13.70
  • ZNTL $5.44
  • Technical
  • Relative Strength Index (RSI)
  • ACNT 48.83
  • ZNTL 44.51
  • Support Level
  • ACNT $12.50
  • ZNTL $1.13
  • Resistance Level
  • ACNT $12.93
  • ZNTL $1.39
  • Average True Range (ATR)
  • ACNT 0.40
  • ZNTL 0.12
  • MACD
  • ACNT 0.01
  • ZNTL -0.03
  • Stochastic Oscillator
  • ACNT 47.58
  • ZNTL 26.83

About ACNT Ascent Industries Co.

Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: